Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MERCK-KGAA-436395/news/Merck-FDA-Accepts-sBLA-and-Grants-Priority-Review-for-BAVENCIO-avelumab-Plus-INLYTA-axitini-27995826/?utm_source=whatsapp&utm_medium=social&utm_campaign=share